MRK · Merck & Co Inc
United States · RS rating 91 · As of 2026-11-03
| Price | 144.67 USD |
|---|---|
| 1-day change | -2.5% |
| RS rating (overall / 1M / 3M / 12M) | 91 / 68 / 84 / 90 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 43 / 48 / 40 |
| Industry group (rank) | Medical-Ethical Drugs (94) |
| EPS growth Q/Q | -48.7% |
| Sales growth Q/Q | -5.1% |
| Distance from 52-week high | +7.5% |
| Market cap (USD) | $283.1B |